Same heterogeneity between the different product categories that make up the sector: among the top five in terms of market share, antacids come first in terms of growth, which in the mobile year recorded an increase of 19.4% to which they contribute a lot volumes (+7.3%) as well as prices (+11.3%). Probiotics (+7.5%) and calming sleeping pills (+7.3%) are also doing well, while cholesterol regulators are in trouble and remain almost unchanged (-0.3%, again in values) thanks only to the increase in prices (+1.9%, see above). Regardless of the trends, in any case, an analysis by category reveals a sufficiently polarized market, in which the first 15 segments by market share bring together 64% of the sector’s turnover and are growing in the moving year of 4 %: in order, they are probiotics (569 million euros), mineral supplements (384 million), antacids/heartburn (223 million) cholesterol regulators (217 million), sedatives and sleeping pills (214 million), stomach products and digestive tract (198 million), laxatives (195), multivitamins and minerals (178), tonics (173), antitussives (157), B vitamins (133), products for urinary diseases (130), other supplements ( 125), ophthalmic (121) and immunostimulants (120 million euros, again in the rolling year).
